New Leaf Ventures II, L.P.
SEC-identified person · CIK 1441439 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Principia Biopharma Inc. PRNB | Officer | filed 2018 - 2019 |
| Neuronetics, Inc. STIM | Officer | filed 2018 - 2018 |
| Irhythm Technologies, Inc. IRTC | Officer | filed 2016 - 2016 |
| MEI Pharma, Inc. MSHL | Officer | filed 2012 - 2015 |
| Versartis, Inc. VSAR | Director | filed 2014 - 2014 |
| Durata Therapeutics, Inc. DRTX | Officer | filed 2012 - 2014 |
| Chimerix INC CRMX | Officer | filed 2013 - 2014 |
| Oxford Immunotec Global PLC OXFD | Director | filed 2013 - 2013 |
| World Heart Corp whrt | Officer | filed 2008 - 2012 |
| Icagen INC ICGN | Officer | filed 2011 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.